{"id":"W1998297722","doi":"10.1111/j.1365-2141.2008.07409.x","title":"High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Neutropenia; Refractory (planetary science); Discontinuation; Internal medicine; Adverse effect; Gastroenterology; Progressive disease; Peripheral neuropathy; Surgery; Toxicity; Chemotherapy; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002377799,0.0003391929,0.001677317,0.0003202644,0.0002122746,0.0005417957,0.0003914071,0.0006791024,0.0008605029],"category_scores_gemma":[0.002154472,0.0001806207,0.0005375366,0.0004514944,0.0003587358,0.0003526492,0.0002702765,0.0007246013,0.0003014236],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003875688,"about_ca_system_score_gemma":0.0003350012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002995258,"about_ca_topic_score_gemma":0.0004532006,"domain_scores_codex":[0.9990242,0.0005557493,0.00007123556,0.0001412877,0.0001304062,0.00007714133],"domain_scores_gemma":[0.9985422,0.0006118672,0.0003551612,0.00009992831,0.00006284957,0.0003279865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.140436,0.005504446,0.4539616,0.0007505303,0.0009003301,0.001577512,0.0004472204,0.001916092,0.04355179,0.0001164316,0.005355024,0.3454832],"study_design_scores_gemma":[0.02660906,0.06209533,0.89156,0.00009186048,0.0005558233,0.004431929,0.0001138937,0.00282762,0.006518283,0.0001813873,0.004950067,0.00006463863],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928866,0.005321595,0.0003234758,0.0003366808,0.00002798685,0.0001211709,0.000192303,0.00007043272,0.0007197218],"genre_scores_gemma":[0.9967467,0.0009577845,0.0007273458,0.0005330981,0.0001075696,0.00009965069,0.0005691853,0.00002021552,0.0002384621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002377799,"threshold_uncertainty_score":0.01257515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03682708077172939,"score_gpt":0.3573689208051373,"score_spread":0.3205418400334079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}